Black Rock Inc. Catalyst Biosciences, Inc. Transaction History

Black Rock Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.33 - $0.65 $33 - $66	102 Added 0.07%	153,759 $73,000
Q2 2023 Aug 11, 2023	SELL	$0.2 - $0.35 $3,249 - $5,686	-16,247 Reduced 9.56%	153,657 $53,000
Q1 2023 May 12, 2023	SELL	$0.19 - $0.64 $1,797 - $6,053	-9,458 Reduced 5.27%	169,904 $35,000
Q4 2022 Feb 13, 2023	SELL	$0.49 - $0.57 $90 - $105	-185 Reduced 0.1%	179,362 $95,000
Q3 2022 Nov 14, 2022	BUY	$0.49 - $1.95 $1,574 - $6,267	3,214 Added 1.82%	179,547 $90,000
Q2 2022 Aug 12, 2022	SELL	$0.36 - $1.78 $27,810 - $137,508	-77,252 Reduced 30.46%	176,333 $314,000
Q1 2022 May 12, 2022	SELL	$0.51 - $1.0 $1,886 - $3,699	-3,699 Reduced 1.44%	253,585 $168,000
Q4 2021 Feb 10, 2022	SELL	$0.91 - $4.16 $12,224 - $55,885	-13,434 Reduced 4.96%	257,284 $235,000
Q3 2021 Nov 09, 2021	SELL	$3.78 - $5.18 $45,756 - $62,703	-12,105 Reduced 4.28%	270,718 $1.11 Million
Q2 2021 Aug 11, 2021	BUY	$4.1 - $5.33 $1.16 Million - $1.51 Million	282,823 New	282,823 $1.23 Million

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.